The retatrutide dose schedule still recommends starting at a conservative dose to assess tolerance of the glucagon component, even if you were on high-dose tirzepatide previously
Nausea, vomiting and other gastrointestinal effects are the most commonly reported concerns, and for many people the side effect profile matters as much as the weight loss results when deciding which medication to try
Microdosing offers a solution by reducing these issues while still delivering meaningful benefits
FDA approves Wegovy weight loss pill The Food and Drug Administration approved a pill version of Wegovy, Novo Nordisk's blockbuster weight loss drug
Retatrutide (RETA-40) 107mg research peptide is not intended for human or animal consumption
With ongoing support, monitoring, and encouragement, our team works closely with you to maximize your progress and keep you motivated throughout your weight loss journey